JP2017532005A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017532005A5 JP2017532005A5 JP2017508053A JP2017508053A JP2017532005A5 JP 2017532005 A5 JP2017532005 A5 JP 2017532005A5 JP 2017508053 A JP2017508053 A JP 2017508053A JP 2017508053 A JP2017508053 A JP 2017508053A JP 2017532005 A5 JP2017532005 A5 JP 2017532005A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- amino
- light chain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14180765.1A EP2985296A1 (en) | 2014-08-13 | 2014-08-13 | Antibodies specific for MMP9 |
| EP14180765.1 | 2014-08-13 | ||
| PCT/EP2015/068645 WO2016023979A1 (en) | 2014-08-13 | 2015-08-13 | Antibodies specific for mmp9 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017532005A JP2017532005A (ja) | 2017-11-02 |
| JP2017532005A5 true JP2017532005A5 (https=) | 2018-09-20 |
| JP6856523B2 JP6856523B2 (ja) | 2021-04-07 |
Family
ID=51301193
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017508053A Expired - Fee Related JP6856523B2 (ja) | 2014-08-13 | 2015-08-13 | Ｍｍｐ９特異的な抗体 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US10364296B2 (https=) |
| EP (2) | EP2985296A1 (https=) |
| JP (1) | JP6856523B2 (https=) |
| KR (1) | KR20170041222A (https=) |
| CN (1) | CN106573984A (https=) |
| AU (1) | AU2015303183B2 (https=) |
| BR (1) | BR112017002703A2 (https=) |
| CA (1) | CA2956986A1 (https=) |
| ES (1) | ES2784271T3 (https=) |
| MX (1) | MX380238B (https=) |
| PL (1) | PL3180362T3 (https=) |
| RU (1) | RU2714043C2 (https=) |
| WO (1) | WO2016023979A1 (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3440113A1 (en) | 2016-04-08 | 2019-02-13 | Gilead Sciences, Inc. | Compositions and methods for treating cancer, inflammatory diseases and autoimmune diseases |
| US10894837B2 (en) | 2016-12-16 | 2021-01-19 | Université De Bordeaux | MMP9 inhibitors and uses thereof in the prevention or treatment of a depigmenting disorder |
| TW202417517A (zh) | 2017-06-02 | 2024-05-01 | 德商麥克專利有限公司 | 與ｍｍｐ１３結合之免疫球蛋白 |
| US20200124604A1 (en) * | 2017-06-30 | 2020-04-23 | National Institutes Of Biomedical Innovation, Health And Nutrition | Biomarker for detecting colorectal cancer |
| EP3656861B1 (en) | 2017-07-18 | 2025-07-23 | Daiichi Sankyo Company, Limited | Active mmp9-binding peptide |
| US12053523B2 (en) | 2017-12-13 | 2024-08-06 | North Carolina State University | Compositions comprising chemotherapeutic agents and checkpoint inhibitors and methods of use |
| IL276089B2 (en) * | 2018-01-22 | 2024-07-01 | Liquid Biopsy Res Llc | Methods for colon cancer detection and treatment monitoring |
| CN108277214B (zh) * | 2018-02-23 | 2021-07-06 | 广东医科大学 | 一种应激磷酸化抗原多肽、抗体、制备方法以及应用 |
| WO2020237092A2 (en) * | 2019-05-21 | 2020-11-26 | The Regents Of The University Of California | Mmp-9 antibodies and methods of use thereof |
| CN110885375B (zh) * | 2019-12-20 | 2021-07-02 | 南京融捷康生物科技有限公司 | 特异性针对mmp-9蛋白锌离子结合结构域的单域抗体及产品与应用 |
| WO2023278491A1 (en) * | 2021-06-28 | 2023-01-05 | Releviate, Llc | Mmp-9 antibodies and uses thereof |
| JP2023021745A (ja) * | 2021-08-02 | 2023-02-14 | 学校法人東京薬科大学 | がん転移抑制のための医薬組成物 |
| CN117327186B (zh) * | 2023-07-12 | 2024-03-12 | 北京达成生物科技有限公司 | 结合mmp3蛋白的双特异性抗体及其用途 |
| AU2024356800A1 (en) | 2023-10-05 | 2026-04-02 | Ashibio, Inc. | Methods and compositions for treating mmp-9 mediated disorders |
| CN117264069B (zh) * | 2023-11-23 | 2024-01-26 | 再少年(北京)生物科技有限公司 | 一种促进皮肤组织再生的工程化外泌体的制备方法及其应用 |
| CN117820488B (zh) * | 2024-01-09 | 2024-10-01 | 首都医科大学附属北京朝阳医院 | 特异性针对mmp-9的抗体对、生物材料及其应用 |
| CN117964771B (zh) * | 2024-04-02 | 2024-06-21 | 智泽童康(广州)生物科技有限公司 | 一种特异性结合mmp7的抗体、mmp7检测试剂及其应用 |
| WO2026076260A1 (en) | 2024-10-03 | 2026-04-09 | Ashibio, Inc. | Methods and compositions for mmp-9 inhibition for use with non-genetic heterotopic ossification disorders |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002066057A2 (en) * | 2001-02-23 | 2002-08-29 | Biophage Inc. | Methods and compositions for preventing and treating neutrophil-mediated diseases |
| GB0516069D0 (en) | 2005-08-04 | 2005-09-14 | Imp College Innovations Ltd | Pharmaceutical and use thereof |
| CN101702906B (zh) * | 2007-02-23 | 2014-02-12 | 耶达研究及发展有限公司 | 用于抑制金属蛋白活性的抗体和含有所述抗体的药物组合物 |
| AU2009221916A1 (en) | 2008-03-03 | 2009-09-11 | Dyax Corp. | Metalloproteinase 9 and metalloproteinase 2 binding proteins |
| JP2011517662A (ja) * | 2008-03-03 | 2011-06-16 | ダイアックス コーポレーション | メタロプロテアーゼ９結合タンパク質 |
| WO2010045388A2 (en) * | 2008-10-14 | 2010-04-22 | Dyax Corp. | Use of mmp-9 and mmp-12 binding proteins for the treatment and prevention of systemic sclerosis |
| US20110135573A1 (en) | 2009-09-03 | 2011-06-09 | Dyax Corp. | Metalloproteinase 9 and metalloproteinase 2 binding proteins |
| EP2608809B1 (en) * | 2010-08-27 | 2019-05-22 | Gilead Biologics, Inc. | Antibodies to matrix metalloproteinase 9 |
| HK1204926A1 (en) * | 2012-02-29 | 2015-12-11 | 吉联亚生物科技有限公司 | Antibodies to matrix metalloproteinase 9 |
| WO2013130078A1 (en) | 2012-02-29 | 2013-09-06 | Gilead Biologics, Inc. | Antibodies to matrix metalloproteinase 9 |
-
2014
- 2014-08-13 EP EP14180765.1A patent/EP2985296A1/en not_active Withdrawn
-
2015
- 2015-08-13 ES ES15749818T patent/ES2784271T3/es active Active
- 2015-08-13 MX MX2017001959A patent/MX380238B/es unknown
- 2015-08-13 CN CN201580043394.1A patent/CN106573984A/zh active Pending
- 2015-08-13 WO PCT/EP2015/068645 patent/WO2016023979A1/en not_active Ceased
- 2015-08-13 EP EP15749818.9A patent/EP3180362B1/en active Active
- 2015-08-13 KR KR1020177004988A patent/KR20170041222A/ko not_active Ceased
- 2015-08-13 RU RU2017107773A patent/RU2714043C2/ru active
- 2015-08-13 US US15/503,447 patent/US10364296B2/en not_active Expired - Fee Related
- 2015-08-13 JP JP2017508053A patent/JP6856523B2/ja not_active Expired - Fee Related
- 2015-08-13 BR BR112017002703-8A patent/BR112017002703A2/pt not_active IP Right Cessation
- 2015-08-13 CA CA2956986A patent/CA2956986A1/en not_active Abandoned
- 2015-08-13 AU AU2015303183A patent/AU2015303183B2/en not_active Ceased
- 2015-08-13 PL PL15749818T patent/PL3180362T3/pl unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017532005A5 (https=) | ||
| RU2017107773A (ru) | Антитела, специфичные к ммр9 | |
| JP2021525546A5 (https=) | ||
| CN104903350B (zh) | 特异于clec14a的新抗体及其用途 | |
| JP2020522261A5 (https=) | ||
| RU2012137515A (ru) | Антитела, связывающиеся с лизилоксидазоподобным ферментом-2 (loxl2), и способы их применения | |
| JP2010526028A5 (https=) | ||
| JP2013506428A5 (https=) | ||
| IL273196B2 (en) | Claudin6 antibodies and methods of treating cancer | |
| RU2013153592A (ru) | Анти-mif антитела | |
| JP2014524733A5 (https=) | ||
| JP2017534259A5 (https=) | ||
| JP2019520034A5 (https=) | ||
| RU2016135962A (ru) | Выделенное антитело, способ его получения, выделенная нуклеиновая кислота, экспрессионная кассета, клетка-хозяин, фармацевтический и диагностический препараты, способ лечения больного, подверженного риску или страдающего от инфекции E.COLI, и способ диагностики определения инфекций E.COLI | |
| JP2024502091A5 (https=) | ||
| JP2018528759A5 (https=) | ||
| KR20250152073A (ko) | 항체, 항원 결합 단편 및 사용 방법 | |
| JP2019500855A (ja) | ヒト化抗−ｂａｇ３抗体 | |
| JPWO2017002919A1 (ja) | 抗プレキシンａ１アゴニスト抗体 | |
| RU2016106708A (ru) | Лекарственное средство, содержащее антитело к фосфолипазе d4 | |
| CN119866346B (zh) | 一种抗vegfa抗体或其抗原结合片段及其应用 | |
| TW202413422A (zh) | 抗體、其抗原結合片段及其藥物用途 | |
| CN118745226B (zh) | 抗ror1抗体及其应用 | |
| EP4146706A1 (en) | Inhibiting anti-enpp1 antibodies | |
| KR20220054600A (ko) | Il-38-특이적 항체 |